PAPER Brown LA, Jin J, Ferrell D, Sadic E, Obregon D, Smith AJ, Tan J, Giunta B
SEARCH RESULTS
331159 RESULTS
PAPER Liu MX, Liu JG, Li H
[Chinese materia medica monomers and components research progress on treating Alzheimer's disease by targeting gamma-secretase].
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Mar;34(3):376-9. PubMed: 24758094PAPER Jung Y, Dickson DW, Murray ME, Whitwell JL, Knopman DS, Boeve BF, Jack CR Jr, Parisi JE, Petersen RC, Josephs KA
TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.
J Neurol. 2014 Jul;261(7):1344-8. Epub 2014 Apr 24 PubMed: 24760339PAPER Woodling NS, Wang Q, Priyam PG, Larkin P, Shi J, Johansson JU, Zagol-Ikapitte I, Boutaud O, Andreasson KI
Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.
J Neurosci. 2014 Apr 23;34(17):5882-94. PubMed: 24760848PAPER Parra-Damas A, Valero J, Chen M, España J, Martín E, Ferrer I, Rodríguez-Alvarez J, Saura CA
Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages.
J Neurosci. 2014 Apr 23;34(17):5776-87. PubMed: 24760838PAPER Guo Y, Zhang Z, Zhou B, Wang P, Yao H, Yuan M, An N, Dai H, Wang L, Zhang X, Liu Y
Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.
Neurosci Bull. 2014 Jun;30(3):477-89. Epub 2014 Apr 23 PubMed: 24760581PAPER Neumann B, Yarman A, Wollenberger U, Scheller F
Characterization of the enhanced peroxidatic activity of amyloid β peptide-hemin complexes towards neurotransmitters.
Anal Bioanal Chem. 2014 May;406(14):3359-64. Epub 2014 Apr 24 PubMed: 24760399PAPER Relkin N
Clinical trials of intravenous immunoglobulin for Alzheimer's disease.
J Clin Immunol. 2014 Jul;34 Suppl 1:S74-9. Epub 2014 Apr 24 PubMed: 24760112PAPER Counts SE, Ray B, Mufson EJ, Perez SE, He B, Lahiri DK
Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease.
J Clin Immunol. 2014 Jul;34 Suppl 1:S80-5. Epub 2014 Apr 24 PubMed: 24760109PAPER Verdan C, Casarsa D, Perrout MR, Santos M, Alves de Souza J, Nascimento O, Freire Coutinho ES, Laks J
Lower mortality rate in people with dementia is associated with better cognitive and functional performance in an outpatient cohort.
Arq Neuropsiquiatr. 2014 Apr;72(4):278-82. PubMed: 24760091PAPER Wajman JR, Oliveira FF, Schultz RR, Marin Sd, Bertolucci PH
Educational bias in the assessment of severe dementia: Brazilian cutoffs for severe Mini-Mental State Examination.
Arq Neuropsiquiatr. 2014 Apr;72(4):273-7. PubMed: 24760090PAPER Walsh KP, Minamide LS, Kane SJ, Shaw AE, Brown DR, Pulford B, Zabel MD, Lambeth JD, Kuhn TB, Bamburg JR
Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.
PLoS One. 2014;9(4):e95995. Epub 2014 Apr 23 PubMed: 24760020PAPER Lee SH, Kim Y, Kim HY, Kim YH, Kim MS, Kong JY, Lee MH, Kim DJ, Ahn YG
Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.
PLoS One. 2014;9(4):e95733. Epub 2014 Apr 23 PubMed: 24760018PAPER Yuzwa SA, Vocadlo DJ
O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Chem Soc Rev. 2014 Oct 7;43(19):6839-58. Epub 2014 Apr 24 PubMed: 24759912PAPER Shin S, Kim JH, Cho JH, Kim GS, Choi SA, Lee JH, For the Alzheimer’s Disease Neuroimaging Initiative
Mild Cognitive Impairment Due to Alzheimer Disease is Less Likely Under the Age of 65.
Alzheimer Dis Assoc Disord. 2014 Apr 22; PubMed: 24759547Current Filters
No filters selected